APT Therapeutics is developing anti-platelet (blood clotting) therapies that may one day be used as a treatment for heart attack victims and stroke patients

Akermin is developing stabilized enzymes for portable biofuel cells.

Cardialen’s mission is to restore and maintain normal cardiac rhythm with pain-free, implantable cardioverters, focusing initially on atrial fibrillation and atrial flutter.

 ISW Group is developing dermatological products for the treatment of acute skin disorders.

Medros is utilizing engineered fruit flies to develop a novel, whole organism approach to drug screening for cancer and diabetes to increase the speed and lower the cost of drug development. 

Neurolutions is developing a brain-computer interface (BCI) to allow control of a computer using thought alone.

PixelEXX Systems is developing nano-scale, multifunctional sensors capable of detecting changes in the internal structures of a cell. 

Venganza has applied gene-silencing technology to fight fungal pathogens in agricultural crops.